32 results on '"Haseda Y"'
Search Results
2. Epidermolysis bullosa hereditaria dystrophica dominant with extensive skin defect at birth
- Author
-
Haseda, Y., Akahane, T., and Tsukada, S.
- Published
- 1983
- Full Text
- View/download PDF
3. Cephalometric analysis of patients with unoperated submucous cleft palate. (Japanese) Jpn
- Author
-
Harii, Kiyonori, primary, Haseda, Y., additional, and Tsukada, S., additional
- Published
- 1989
- Full Text
- View/download PDF
4. Health Activities in H-school-district of Toyama Prefecture by Means of Clinic Service
- Author
-
Shibutani, T., primary, Okumura, T., additional, Abe, Y., additional, Yasuda, J., additional, and Haseda, Y., additional
- Published
- 1967
- Full Text
- View/download PDF
5. Low-frequency CD8 + T cells induced by SIGN-R1 + macrophage-targeted vaccine confer SARS-CoV-2 clearance in mice.
- Author
-
Muraoka D, Moi ML, Muto O, Nakatsukasa T, Deng S, Takashima C, Yamaguchi R, Sawada SI, Hayakawa H, Nguyen TTN, Haseda Y, Soga T, Matsushita H, Ikeda H, Akiyoshi K, and Harada N
- Abstract
Vaccine-induced T cells and neutralizing antibodies are essential for protection against SARS-CoV-2. Previously, we demonstrated that an antigen delivery system, pullulan nanogel (PNG), delivers vaccine antigen to lymph node medullary macrophages and thereby enhances the induction of specific CD8
+ T cells. In this study, we revealed that medullary macrophage-selective delivery by PNG depends on its binding to a C-type lectin SIGN-R1. In a K18-hACE2 mouse model of SARS-CoV-2 infection, vaccination with a PNG-encapsulated receptor-binding domain of spike protein decreased the viral load and prolonged the survival in the CD8+ T cell- and B cell-dependent manners. T cell receptor repertoire analysis revealed that although the vaccine induced T cells at various frequencies, low-frequency specific T cells mainly promoted virus clearance. Thus, the induction of specific CD8+ T cells that respond quickly to viral infection, even at low frequencies, is important for vaccine efficacy and can be achieved by SIGN-R1+ medullary macrophage-targeted antigen delivery., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
6. Verification of embedding conditions for FBG sensor into textile product for the development of wearable healthcare sensor.
- Author
-
Koyama S, Ohno Y, Haseda Y, Satou Y, and Ishizawa H
- Subjects
- Delivery of Health Care, Heart Rate, Humans, Textiles, Optical Fibers, Wearable Electronic Devices
- Abstract
Background: To develop wearable healthcare sensors that use fiber Bragg grating (FBG) sensors, a stretch textile product with an embedded FBG sensor is required., Objective: The FBG sensor, which is an optical fiber, was embedded into a textile product following a wavy pattern by using a warp knitting machine., Methods: When an optical fiber is embedded in a textile product, the effect of the cycle length of wavy pattern and the number of cycles on the optical loss is verified. The shorter the cycle length of the wavy pattern of the optical fiber, and more increase in the number of cycles, the longer the textile product in which the optical fiber is embedded can expand and contract. However, when the cycle length of the wave pattern is 30 mm (shortest), large in optical loss, the pulse wave signal cannot be measured. If the cycle length of the wavy pattern is 50 mm or more, small in optical loss, the pulse wave signal is measured., Results: Compared with a straight pattern embedding FBG sensor, the amplitude value of the pulse wave signal measured with a cycle length of 50 mm is large, therefore the sensor sensitivity in this state is greater. This result is consistent with the measurement sensitivity depending on the angle of installation with respect to the direction of the artery., Conclusion: With a cycle length of wavy pattern of 50 mm and 4 cycles, a stretch textile product with an embedded FBG sensor can be fabricated. Pulse wave signals are measured with this textile product, and the development of wearable healthcare sensors is expected.
- Published
- 2022
- Full Text
- View/download PDF
7. Nocturnal Blood Pressure Fluctuations in Patients with Rapid Eye Movement-Related Obstructive Sleep Apnea.
- Author
-
Kumagai H, Sawatari H, Hoshino T, Konishi N, Kiyohara Y, Kawaguchi K, Tsuda H, Haseda Y, Sasanabe R, and Shiomi T
- Abstract
Rapid eye movement-related obstructive sleep apnea (REM-related OSA) is a polysomnographic phenotype. Nocturnal blood pressure (BP) fluctuations remain unclear in patients with REM-related OSA. We studied 27 patients with REM-related OSA, categorized as having REM-apnea-hypopnea index (REM-AHI) ≥ 5/h, REM-AHI/non-REM-AHI ≥ 2, and non-REM-AHI < 15/h. Beat-to-beat systolic BP (SBP) variability and nocturnal SBP fluctuation patterns using pulse transit time (PTT) were investigated. The maximum increase and average nocturnal SBP were significantly higher in males than in females ( p = 0.003 and p = 0.008, respectively). The rate of non-dipping patterns in nocturnal SBP fluctuations was 63% in all patients (males, 70%; females, 50%). Epworth Sleepiness Scale (ESS) and Self-rating Depression Scale (SDS) scores in females were higher than those in males (8.4 ± 6.1 vs. 13.4 ± 5.4 points, p = 0.04; 43.8 ± 7.9 vs. 52 ± 11.6 points, p = 0.04, respectively). A high proportion of patients with REM-related OSA had a non-dipping pattern. Using PPT, we observed that in patients with REM-related OSA, SBP variability was greater in males. Despite clinical symptoms being slightly more severe in females, nocturnal SBP fluctuations should be considered in male patients with REM-related OSA.
- Published
- 2021
- Full Text
- View/download PDF
8. Development of combination adjuvant for efficient T cell and antibody response induction against protein antigen.
- Author
-
Haseda Y, Munakata L, Kimura C, Kinugasa-Katayama Y, Mori Y, Suzuki R, and Aoshi T
- Subjects
- Aluminum pharmacology, Animals, Antibody Formation immunology, Cell Movement immunology, Fatty Acids, Monounsaturated pharmacology, Humans, Immunity immunology, Liposomes immunology, Lymph Nodes immunology, Mice, Quaternary Ammonium Compounds pharmacology, T-Lymphocytes, Cytotoxic drug effects, T-Lymphocytes, Cytotoxic immunology, Vaccination methods, Vaccines immunology, Adjuvants, Immunologic pharmacology, Antigens immunology, Proteins immunology, T-Lymphocytes immunology
- Abstract
Most current clinical vaccines work primarily by inducing the production of neutralizing antibodies against pathogens. Vaccine adjuvants that efficiently induce T cell responses to protein antigens need to be developed. In this study, we developed a new combination adjuvant consisting of 1,2-dioleoyl-3-trimethylammonium propane (DOTAP), D35, and an aluminum salt. Among the various combinations tested, the DOTAP/D35/aluminum salt adjuvant induced strong T cell and antibody responses against the model protein antigen with a single immunization. Adjuvant component and model antigen interaction studies in vitro also revealed that the strong mutual interactions among protein antigens and other components were one of the important factors for this efficient immune induction by the novel combination adjuvant. In addition, in vivo imaging of the antigen distribution suggested that the DOTAP component in the combination adjuvant formulation elicited transient antigen accumulation at the draining lymph nodes, possibly by antigen uptake DC migration. These results indicate the potential of the new combination adjuvant as a promising vaccine adjuvant candidate to treat infectious diseases and cancers., Competing Interests: These authors disclose the following: Yasunari Haseda, Lisa Munakata, Ryo Suzuki, Yasuko Mori, and Taiki Aoshi filed a patent application related to the content of this manuscript[Immunostimulants: Patent Application Number(JAPAN) 227061(2018)]. The other authors declare no conflicts of interest.
- Published
- 2021
- Full Text
- View/download PDF
9. Microfluidics sorting enables the isolation of an intact cellular pair complex of CD8+ T cells and antigen-presenting cells in a cognate antigen recognition-dependent manner.
- Author
-
Kuwabara S, Tanimoto Y, Okutani M, Jie M, Haseda Y, Kinugasa-Katayama Y, and Aoshi T
- Subjects
- Animals, CD8-Positive T-Lymphocytes metabolism, Cell Communication immunology, Cell Line, Tumor, Flow Cytometry methods, HEK293 Cells, Humans, Mice, Inbred C57BL, Mice, Knockout, Mice, Transgenic, Receptors, Antigen, T-Cell genetics, Receptors, Antigen, T-Cell immunology, Receptors, Antigen, T-Cell metabolism, Reproducibility of Results, Mice, Antigen Presentation immunology, Antigen-Presenting Cells immunology, Antigens immunology, CD8-Positive T-Lymphocytes immunology, Cell Separation methods, Microfluidics methods
- Abstract
Adaptive immune responses begin with cognate antigen presentation-dependent specific interaction between T cells and antigen-presenting cells. However, there have been limited reports on the isolation and analysis of these cellular complexes of T cell-antigen-presenting cell (T/APC). In this study, we successfully isolated intact antigen-specific cellular complexes of CD8+ T/APC by utilizing a microfluidics cell sorter. Using ovalbumin (OVA) model antigen and OT-I-derived OVA-specific CD8+ T cells, we analyzed the formation of antigen-specific and antigen-non-specific T/APC cellular complexes and revealed that the antigen-specific T/APC cellular complex was highly stable than the non-specific one, and that the intact antigen-specific T/APC complex can be retrieved as well as enriched using a microfluidics sorter, but not a conventional cell sorter. The single T/APC cellular complex obtained can be further analyzed for the sequences of T cell receptor Vα and Vβ genes as well as cognate antigen information simultaneously. These results suggested that this approach can be applied for other antigen and CD8+ T cells of mice and possibly those of humans. We believe that this microfluidics sorting method of the T/APC complex will provide useful information for future T cell immunology research., Competing Interests: These authors disclose the following: Soichiro Kuwabara and Mie Okutani are employed by the Research Foundation for Microbial Diseases of Osaka University. The remaining authors declare no conflict of interest.
- Published
- 2021
- Full Text
- View/download PDF
10. Comprehensive Screening of Mouse T-Cell Epitopes in Human Herpesvirus 6B Glycoprotein H/L/Q1/Q2 Tetramer Complex.
- Author
-
Okutani M, Kawabata A, Nishimura M, Nagamata S, Kuwabara S, Haseda Y, Munakata L, Suzuki R, Mori Y, and Aoshi T
- Subjects
- Animals, CD4-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes immunology, Cell Line, Tumor, Humans, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Epitopes, T-Lymphocyte immunology, Glycoproteins immunology, Herpesvirus 6, Human immunology, Viral Envelope Proteins immunology
- Abstract
Human herpesvirus 6 (HHV-6) infects over 90% of people. The HHV-6 subtype, HHV-6B in particular, is often associated with exanthem subitum in early childhood. Exanthem subitum is usually self-limiting and good prognosis disease; however, some infants primarily infected with HHV-6B develop encephalitis/encephalopathy, and half of the patients developed encephalopathy reported to have neurological sequelae. Furthermore, after primary infection, HHV-6B remains in a latent state and sometimes reactivated in immunosuppressed patients, causing life-threatening severe encephalopathy. However, effective immunotherapies or vaccines for controlling HHV-6B infection and reactivation have not yet been established. Recently, we have found that the HHV-6B tetrameric glycoprotein (g) complex, gH/gL/gQ1/gQ2 is a promising vaccine candidate, and currently under preclinical development. To confirm our vaccine candidate protein complex induce detectable T-cell responses, in this study, we comprehensively screened CD4
+ and CD8+ T-cell epitopes in the gH/gL/gQ1/gQ2 tetrameric complex protein in mice immunisation model. Both BALB/c and C57BL/6 mice were immunised with the tetrameric complex protein or plasmid DNA encoding gH, gL, gQ1, and gQ2, and then restimulated with 162 20-mer peptides covering the whole gH/gL/gQ1/gQ2 sequences; multiple CD4+ and CD8+ T-cell-stimulating peptides were identified in both BALB/c and C57BL/6 mice. Our study demonstrates that gH/gL/gQ1/gQ2 tetramer-targeted vaccination has potential to induce T-cell responses in two different strains of mice and supports the future development and application of T-cell-inducing vaccine and immunotherapies against HHV-6B., Competing Interests: Mie Okutani and Soichiro Kuwabara are employed by the Research Foundation for Microbial Diseases of Osaka University. Yasunari Haseda, Lisa Munakata, Ryo Suzuki, Yasuko Mori, and Taiki Aoshi have filed a patent application related to the content of this manuscript. The remaining authors declare no conflicts of interest., (Copyright © 2020 Mie Okutani et al.)- Published
- 2020
- Full Text
- View/download PDF
11. Tetrameric glycoprotein complex gH/gL/gQ1/gQ2 is a promising vaccine candidate for human herpesvirus 6B.
- Author
-
Wang B, Hara K, Kawabata A, Nishimura M, Wakata A, Tjan LH, Poetranto AL, Yamamoto C, Haseda Y, Aoshi T, Munakata L, Suzuki R, Komatsu M, Tsukamoto R, Itoh T, Nishigori C, Saito Y, Matozaki T, and Mori Y
- Subjects
- Adjuvants, Immunologic pharmacology, Animals, Exanthema Subitum virology, Herpesvirus 6, Human, Humans, Mice, Mice, Inbred BALB C, Exanthema Subitum immunology, Herpesvirus Vaccines immunology, Viral Envelope Proteins immunology
- Abstract
Primary infection of human herpesvirus 6B (HHV-6B) occurs in infants after the decline of maternal immunity and causes exanthema subitum accompanied by a high fever, and it occasionally develops into encephalitis resulting in neurological sequelae. There is no effective prophylaxis for HHV-6B, and its development is urgently needed. The glycoprotein complex gH/gL/gQ1/gQ2 (called 'tetramer of HHV-6B') on the virion surface is a viral ligand for its cellular receptor human CD134, and their interaction is thus essential for virus entry into the cells. Herein we examined the potency of the tetramer as a vaccine candidate against HHV-6B. We designed a soluble form of the tetramer by replacing the transmembrane domain of gH with a cleavable tag, and the tetramer was expressed by a mammalian cell expression system. The expressed recombinant tetramer is capable of binding to hCD134. The tetramer was purified to homogeneity and then administered to mice with aluminum hydrogel adjuvant and/or CpG oligodeoxynucleotide adjuvant. After several immunizations, humoral and cellular immunity for HHV-6B was induced in the mice. These results suggest that the tetramer together with an adjuvant could be a promising candidate HHV-6B vaccine., Competing Interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: Taiki Aoshi are employed by the Research Foundation for Microbial Diseases of Osaka University. Ryo Suzuki, Taiki Aoshi, and Yasuko Mori have filed a patent application related to the content of this manuscript. The remaining authors declare no conflicts.
- Published
- 2020
- Full Text
- View/download PDF
12. Microfluidic-prepared DOTAP nanoparticles induce strong T-cell responses in mice.
- Author
-
Haseda Y, Munakata L, Meng J, Suzuki R, and Aoshi T
- Subjects
- Adjuvants, Immunologic chemistry, Animals, CD4-Positive T-Lymphocytes drug effects, CD4-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes drug effects, CD8-Positive T-Lymphocytes immunology, Humans, Immunity, Cellular immunology, Liposomes pharmacology, Mice, Microfluidics, Nanoparticles chemistry, Vaccines chemistry, Adjuvants, Immunologic pharmacology, Fatty Acids, Monounsaturated pharmacology, Immunity, Cellular drug effects, Quaternary Ammonium Compounds pharmacology, Vaccines pharmacology
- Abstract
For the induction of antigen-specific T-cell responses by vaccination, an appropriate immune adjuvant is required. Vaccine adjuvants generally provide two functions, namely, immune potentiator and delivery, and many adjuvants that can efficiently induce T-cell responses are known to have the combination of these two functions. In this study, we explored a cationic lipid DOTAP-based adjuvant. We found that the microfluidic preparation of DOTAP nanoparticles induced stronger CD4+ and CD8+ T-cell responses than liposomal DOTAP. The further addition of Type-A CpG D35 in DOTAP nanoparticles increased the induction of T-cell responses, particularly in CD4+ T cells. Further investigations revealed that the size of DOTAP nanoparticles, prepared buffer conditions, and physicochemical interaction with vaccine antigen are important factors for the efficient induction of T-cell responses with a relatively small antigen dose. These results suggested that microfluidic-prepared DOTAP nanoparticles plus D35 are a promising adjuvant for a vaccine that induces therapeutic T-cell responses for treating cancer and infectious diseases., Competing Interests: Some of the authors have filed a patent application (Application Number 2018-227061) related to the content of this manuscript. However, this does not alter our adherence to PLOS ONE policies on sharing data and materials.
- Published
- 2020
- Full Text
- View/download PDF
13. Measurement of Pulse Wave Signals and Blood Pressure by a Plastic Optical Fiber FBG Sensor.
- Author
-
Haseda Y, Bonefacino J, Tam HY, Chino S, Koyama S, and Ishizawa H
- Subjects
- Algorithms, Calibration, Humans, Least-Squares Analysis, Optical Fibers, Physical Phenomena, Reproducibility of Results, Signal Processing, Computer-Assisted instrumentation, Blood Pressure physiology, Blood Pressure Determination instrumentation, Heart Rate physiology, Plastics chemistry
- Abstract
Fiber Bragg grating (FBG) sensors fabricated in silica optical fiber (Silica-FBG) have been used to measure the strain of human arteries as pulse wave signals. A variety of vital signs including blood pressure can be derived from these signals. However, silica optical fiber presents a safety risk because it is easily fractured. In this research, an FBG sensor fabricated in plastic optical fiber (POF-FBG) was employed to resolve this problem. Pulse wave signals were measured by POF-FBG and silica-FBG sensors for four subjects. After signal processing, a calibration curve was constructed by partial least squares regression, then blood pressure was calculated from the calibration curve. As a result, the POF-FBG sensor could measure the pulse wave signals with an signal to noise (SN) ratio at least eight times higher than the silica-FBG sensor. Further, the measured signals were substantially similar to those of an acceleration plethysmograph (APG). Blood pressure is measured with low error, but the POF-FBG APG correlation is distributed from 0.54 to 0.72, which is not as high as desired. Based on these results, pulse wave signals should be measured under a wide range of reference blood pressures to confirm the reliability of blood pressure measurement uses POF-FBG sensors.
- Published
- 2019
- Full Text
- View/download PDF
14. Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in mice.
- Author
-
Munakata L, Tanimoto Y, Osa A, Meng J, Haseda Y, Naito Y, Machiyama H, Kumanogoh A, Omata D, Maruyama K, Yoshioka Y, Okada Y, Koyama S, Suzuki R, and Aoshi T
- Subjects
- Animals, Antineoplastic Agents pharmacology, Blood Cells metabolism, Drug Compounding, Drug Stability, Drug Therapy, Combination, Fatty Acids, Monounsaturated chemistry, Humans, Immunosuppression Therapy, Immunotherapy, Liver metabolism, Mice, Neoplasms drug therapy, Neoplasms, Experimental therapy, Oligodeoxyribonucleotides pharmacology, Phosphatidylethanolamines chemistry, Phosphorylcholine chemistry, Programmed Cell Death 1 Receptor metabolism, Quaternary Ammonium Compounds chemistry, Antineoplastic Agents chemistry, CD8-Positive T-Lymphocytes drug effects, Lipids chemistry, Nanocapsules chemistry, Oligodeoxyribonucleotides chemistry, Tumor Microenvironment drug effects
- Abstract
Type-A CpG oligodeoxynucleotides (ODNs), which have a natural phosphodiester backbone, is one of the highest IFN-α inducer from plasmacytoid dendritic cells (pDC) via Toll-like receptor 9 (TLR9)-dependent signaling. However, the in vivo application of Type-A CpG has been limited because the rapid degradation in vivo results in relatively weak biological effect compared to other Type-B, -C, and -P CpG ODNs, which have nuclease-resistant phosphorothioate backbones. To overcome this limitation, we developed lipid nanoparticles formulation containing a Type-A CpG ODN, D35 (D35LNP). When tested in a mouse tumor model, intratumoral and intravenous D35LNP administration significantly suppressed tumor growth in a CD8 T cell-dependent manner, whereas original D35 showed no efficacy. Tumor suppression was associated with Th1-related gene induction and activation of CD8 T cells in the tumor. The combination of D35LNP and an anti-PD-1 antibody increased the therapeutic efficacy. Importantly, the therapeutic schedule and dose of intravenous D35LNP did not induce apparent liver toxicity. These results suggested that D35LNP is a safe and effective immunostimulatory drug formulation for cancer immunotherapy., (Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
15. Wireless, Portable Fiber Bragg Grating Interrogation System Employing Optical Edge Filter.
- Author
-
Ogawa K, Koyama S, Haseda Y, Fujita K, Ishizawa H, and Fujimoto K
- Abstract
A small-size, high-precision fiber Bragg grating interrogator was developed for continuous plethysmograph monitoring. The interrogator employs optical edge filters, which were integrated with a broad-band light source and photodetector to demodulate the Bragg wavelength shift. An amplifier circuit was designed to effectively amplify the plethysmograph signal, obtained as a small vibration of optical power on the large offset. The standard deviation of the measured Bragg wavelength was about 0.1 pm. The developed edge filter module and amplifier circuit were encased with a single-board computer and communicated with a laptop computer via Wi-Fi. As a result, the plethysmograph was clearly obtained remotely, indicating the possibility of continuous vital sign measurement.
- Published
- 2019
- Full Text
- View/download PDF
16. A Perifascial Areolar Tissue Graft With Topical Administration of Basic Fibroblast Growth Factor for Treatment of Complex Wounds With Exposed Tendons and/or Bones.
- Author
-
Miyanaga T, Haseda Y, Daizo H, Yamashita M, Yamashita A, Kishibe M, and Shimada K
- Subjects
- Administration, Topical, Adult, Aged, Aged, 80 and over, Cohort Studies, Graft Rejection, Graft Survival drug effects, Humans, Japan, Male, Middle Aged, Prognosis, Plastic Surgery Procedures methods, Retrospective Studies, Severity of Illness Index, Skin Transplantation methods, Soft Tissue Injuries diagnosis, Soft Tissue Injuries drug therapy, Soft Tissue Injuries surgery, Surgical Flaps blood supply, Treatment Outcome, Wound Healing physiology, Wounds and Injuries diagnosis, Young Adult, Fibroblast Growth Factor 2 administration & dosage, Surgical Flaps transplantation, Wound Healing drug effects, Wounds and Injuries drug therapy, Wounds and Injuries surgery
- Abstract
The management of wounds with tendon and/or bone exposure is challenging because of the insufficient blood supply to the wound bed. We describe our experience with 19 patients using a perifascial areolar tissue (PAT) graft with topical administration of basic fibroblast growth factor (bFGF) in the treatment of complex wounds with exposed tendons and/or bones in the extremities. Using a PAT graft is minimally invasive and technically easy, and the donor site is relatively preserved. However, PAT grafts for the treatment of a complex wound with large areas of exposed tendons and/or bones have sometimes failed to survive because of insufficient vascularization of the wound bed. Therefore, topical administration of bFGF, which promotes angiogenesis, was added to the graft. All grafts showed good graft survival and successfully covered the tendons and bones. Topical administration of bFGF accelerated vascularization in the PAT graft and facilitated wound healing by increasing the blood supply to the wound bed and achieved success with the PAT graft. In conclusion, using a PAT graft with topical administration of bFGF is a suitable option for the treatment of complex wounds with a large proportion of exposed tendons and/or bones. With minimal damage to the tissues near the wound, the PAT graft can be a useful option for limb salvage and could become a valuable tool for reconstructive surgeons., (Copyright © 2017 The American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
17. Quantifying the relative immune cell activation from whole tissue/organ-derived differentially expressed gene data.
- Author
-
Wijaya E, Igarashi Y, Nakatsu N, Haseda Y, Billaud J, Chen YA, Mizuguchi K, Yamada H, Ishii K, and Aoshi T
- Subjects
- Animals, Biopsy, DNA Contamination, Databases, Genetic, Gastrointestinal Tract pathology, Human papillomavirus 16 immunology, Humans, Inflammatory Bowel Diseases drug therapy, Infliximab therapeutic use, Mice, Software, Spleen metabolism, Virion immunology, Leukocytes, Mononuclear metabolism, Organ Specificity genetics, Organ Specificity immunology, Transcriptome
- Abstract
Evaluation of immune responses in individual immune cell types is important for the development of new medicines. Here, we propose a computational method designated ICEPOP (Immune CEll POPulation) to estimate individual immune cell type responses from bulk tissue and organ samples. The relative gene responses are scored for each cell type by using the data from differentially expressed genes derived from control- vs drug-treated sample pairs, and the data from public databases including ImmGen and IRIS, which contain gene expression profiles of a variety of immune cells. By ICEPOP, we analysed cell responses induced by vaccine-adjuvants in the mouse spleen, and extended the analyses to human peripheral blood mononuclear cells and gut biopsy samples focusing on human papilloma virus vaccination and inflammatory bowel disease treatment with Infliximab. In both mouse and human datasets, our method reliably quantified the responding immune cell types and provided insightful information, demonstrating that our method is useful to evaluate immune responses from bulk sample-derived gene expression data. ICEPOP is available as an interactive web site ( https://vdynamics.shinyapps.io/icepop/ ) and Python package ( https://github.com/ewijaya/icepop ).
- Published
- 2017
- Full Text
- View/download PDF
18. Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus.
- Author
-
Urakami A, Sakurai A, Ishikawa M, Yap ML, Flores-Garcia Y, Haseda Y, Aoshi T, Zavala FP, Rossmann MG, Kuno S, Ueno R, and Akahata W
- Subjects
- Animals, Disease Models, Animal, Female, Macaca mulatta, Malaria Vaccines administration & dosage, Malaria Vaccines genetics, Male, Mice, Inbred BALB C, Plasmodium falciparum genetics, Plasmodium falciparum immunology, Plasmodium yoelii genetics, Plasmodium yoelii immunology, Protozoan Proteins genetics, Vaccines, Synthetic administration & dosage, Vaccines, Synthetic genetics, Vaccines, Synthetic immunology, Vaccines, Virus-Like Particle administration & dosage, Vaccines, Virus-Like Particle genetics, Chikungunya virus genetics, Drug Carriers, Malaria prevention & control, Malaria Vaccines immunology, Protozoan Proteins immunology, Vaccines, Virus-Like Particle immunology
- Abstract
Virus-like particles (VLPs) are noninfectious multiprotein structures that are engineered to self-assemble from viral structural proteins. Here, we developed a novel VLP-based vaccine platform utilizing VLPs from the chikungunya virus. We identified two regions within the envelope protein, a structural component of chikungunya, where foreign antigens can be inserted without compromising VLP structure. Our VLP displays 480 copious copies of an inserted antigen on the VLP surface in a highly symmetric manner and is thus capable of inducing strong immune responses against any inserted antigen. Furthermore, by mimicking the structure of the immature form of the virus, we altered our VLP's in vivo dynamics and enhanced its immunogenicity. We used the circumsporozoite protein (CSP) of the Plasmodium falciparum malaria parasite as an antigen and demonstrated that our VLP-based vaccine elicits strong immune responses against CSP in animals. The sera from immunized monkeys protected mice from malaria infection. Likewise, mice vaccinated with P. yoelii CSP-containing VLPs were protected from an infectious sporozoite challenge. Hence, our uniquely engineered VLP platform can serve as a blueprint for the development of vaccines against other pathogens and diseases., (Copyright © 2017 Urakami et al.)
- Published
- 2017
- Full Text
- View/download PDF
19. Minced skin grafting for promoting epithelialization of the donor site after split-thickness skin grafting.
- Author
-
Miyanaga T, Haseda Y, and Sakagami A
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Alginates, Bandages, Biocompatible Materials, Child, Child, Preschool, Female, Glucuronic Acid, Hexuronic Acids, Humans, Infant, Male, Middle Aged, Retrospective Studies, Thigh, Wound Healing, Young Adult, Burns surgery, Hidradenitis Suppurativa surgery, Re-Epithelialization, Skin Neoplasms surgery, Skin Transplantation methods, Skin Ulcer surgery, Transplant Donor Site pathology
- Abstract
It is important to minimize time to healing in the donor site after split-thickness skin grafting (STSG). It has been shown that minced skin grafting improves the appearance of the STSG donor site. The objective of this study was to investigate whether mincing the leftover harvested skin and grafting it back onto the donor site during minced grafting (MG) reduces healing time of the donor site. Normal healing time of the donor site after STSG is 10-20 days; therefore, healing time more than a month is abnormal. Out of the 96 patients (MG: controls=48:48) initially selected for this study, 7 patients (1 in the MG group and 6 in the control group) with abnormal wound healing (healing time >1 month) were excluded because their healing times were too long (from 1.5 to 6 months). All donor sites were on the lateral thigh. A part of the skin was minced and uniformly spread on the entire surface of the donor site. A calcium alginate dressing was applied and covered with a protective gauze dressing. Patients in the control group were treated identically, except that MG was not performed. MG of the STSG donor site reduced the average time to healing by approximately 4days (9.1 vs. 13.2). This effect was independent from the size of the donor site and MG/STSG mass ratio. This procedure, which makes use of skin leftovers after skin grafting, should be performed prior to applying wound covering material as a means of reducing time to healing and level of patient's discomfort., (Copyright © 2016 Elsevier Ltd and ISBI. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
20. Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines.
- Author
-
Hayashi M, Aoshi T, Haseda Y, Kobiyama K, Wijaya E, Nakatsu N, Igarashi Y, Standley DM, Yamada H, Honda-Okubo Y, Hara H, Saito T, Takai T, Coban C, Petrovsky N, and Ishii KJ
- Subjects
- Animals, Antigens immunology, Biomarkers, Cytokines biosynthesis, Dendritic Cells immunology, Dendritic Cells metabolism, Female, Immunization, Inulin administration & dosage, Liposomes, Lymphocyte Activation, Macrophages immunology, Macrophages metabolism, Male, Mice, Mice, Knockout, Models, Animal, Phagocytosis immunology, Signal Transduction, Th2 Cells immunology, Th2 Cells metabolism, Adjuvants, Immunologic administration & dosage, Inulin analogs & derivatives, Vaccines administration & dosage, Vaccines immunology
- Abstract
Advax, a delta inulin-derived microparticle, has been developed as an adjuvant for several vaccines. However, its immunological characteristics and potential mechanism of action are yet to be elucidated. Here, we show that Advax behaves as a type-2 adjuvant when combined with influenza split vaccine, a T helper (Th)2-type antigen, but behaves as a type-1 adjuvant when combined with influenza inactivated whole virion (WV), a Th1-type antigen. In addition, an adjuvant effect was not observed when Advax-adjuvanted WV vaccine was used to immunize toll-like receptor (TLR) 7 knockout mice which are unable to respond to RNA contained in WV antigen. Similarly, no adjuvant effect was seen when Advax was combined with endotoxin-free ovalbumin, a neutral Th0-type antigen. An adjuvant effect was also not seen in tumor necrosis factor (TNF)-α knockout mice, and the adjuvant effect required the presences of dendritic cells (DCs) and phagocytic macrophages. Therefore, unlike other adjuvants, Advax potentiates the intrinsic or in-built adjuvant property of co-administered antigens. Hence, Advax is a unique class of adjuvant which can potentiate the intrinsic adjuvant feature of the vaccine antigens through a yet to be determined mechanism., (Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
21. RNA is an Adjuvanticity Mediator for the Lipid-Based Mucosal Adjuvant, Endocine.
- Author
-
Hayashi M, Aoshi T, Ozasa K, Kusakabe T, Momota M, Haseda Y, Kobari S, Kuroda E, Kobiyama K, Coban C, and Ishii KJ
- Subjects
- A549 Cells, Alarmins metabolism, Animals, Antibody Formation drug effects, Female, Humans, Inflammasomes metabolism, Lipids pharmacology, Mice, Inbred BALB C, Mice, Inbred C57BL, Mucous Membrane immunology, NLR Family, Pyrin Domain-Containing 3 Protein metabolism, Nucleic Acids metabolism, Toll-Like Receptor 2 metabolism, Toll-Like Receptor 4 metabolism, Adjuvants, Immunologic pharmacology, Lipids chemistry, Mucous Membrane drug effects, RNA pharmacology
- Abstract
Nasal vaccination has the potential to elicit systemic and mucosal immunity against pathogens. However, split and subunit vaccines lack potency at stimulating mucosal immunity, and an adjuvant is indispensable for eliciting potent mucosal immune response to nasal vaccines. Endocine, a lipid-based mucosal adjuvant, potentiates both systemic and mucosal immune responses. Although Endocine has shown efficacy and tolerability in animal and clinical studies, its mechanism of action remains unknown. It has been reported recently that endogenous danger signals are essential for the effects of some adjuvants such as alum or MF59. However, the contribution of danger signals to the adjuvanticity of Endocine has not been explored. Here, we show that RNA is likely to be an important mediator for the adjuvanticity of Endocine. Administration of Endocine generated nucleic acids release, and activated dendritic cells (DCs) in draining lymph nodes in vivo. These results suggest the possibility that Endocine indirectly activates DCs via damage-associated molecular patterns. Moreover, the adjuvanticity of Endocine disappeared in mice lacking TANK-binding kinase 1 (Tbk1), which is a downstream molecule of nucleic acid sensing signal pathway. Furthermore, co-administration of RNase A reduced the adjuvanticity of Endocine. These data suggest that RNA is important for the adjuvanticity of Endocine.
- Published
- 2016
- Full Text
- View/download PDF
22. Optimization of physiological properties of hydroxyapatite as a vaccine adjuvant.
- Author
-
Hayashi M, Aoshi T, Kogai Y, Nomi D, Haseda Y, Kuroda E, Kobiyama K, and Ishii KJ
- Subjects
- Adjuvants, Immunologic administration & dosage, Animals, Durapatite administration & dosage, Female, Mice, Inbred C57BL, Nanoparticles administration & dosage, Vaccines administration & dosage, Adjuvants, Immunologic pharmacology, Chemical Phenomena, Durapatite pharmacology, Vaccines immunology
- Abstract
Various particles such as Alum or silica are known to act as an adjuvant if co-administered with vaccine antigens. Several reports have demonstrated that the adjuvanticity is strongly affected by the physicochemical properties of particles such as the size, shape and surface charge, although the required properties and its relationship to the adjuvanticity are still controversial. Hydroxyapatite particle (HAp) composed of calcium phosphate has been shown to work as adjuvant in mice. However, the properties of HAp required for the adjuvanticity have not been fully characterized yet. In this study, we examined the role of size or shape of HAps in the antibody responses after immunization with antigen. HAps whose diameter ranging between 100 and 400 nm provided significantly higher antibody responses than smaller or larger ones. By comparison between sphere and rod shaped HAps, rod shaped HAps induced stronger inflammasome-dependent IL-1β production than the sphere shaped ones in vitro. However, sphere- and rod-shaped HAp elicited comparable antibody response in WT mice. Vice versa, Nlrp3(-/-), Asc(-/-) or Caspase1(-/-) mice provided comparable level of antibody responses to HAp adjuvanted vaccination. Collectively, our results demonstrated that the size rather than shape is a more critical property, and IL-1β production via NLRP3 inflammasome is dispensable for the adjuvanticity of HAps in mice., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
23. Development of Nonaggregating Poly-A Tailed Immunostimulatory A/D Type CpG Oligodeoxynucleotides Applicable for Clinical Use.
- Author
-
Aoshi T, Haseda Y, Kobiyama K, Narita H, Sato H, Nankai H, Mochizuki S, Sakurai K, Katakai Y, Yasutomi Y, Kuroda E, Coban C, and Ishii KJ
- Subjects
- Animals, Cytokines biosynthesis, Dose-Response Relationship, Drug, Dose-Response Relationship, Immunologic, Fatty Acids, Monounsaturated chemistry, Humans, Influenza Vaccines immunology, Leukocytes, Mononuclear drug effects, Leukocytes, Mononuclear immunology, Leukocytes, Mononuclear metabolism, Macaca fascicularis, Oligodeoxyribonucleotides administration & dosage, Oligodeoxyribonucleotides chemistry, Quaternary Ammonium Compounds chemistry, Solubility, Adjuvants, Immunologic, Oligodeoxyribonucleotides immunology, Poly A chemistry
- Abstract
Immunostimulatory CpG ODNs have been developed and utilized as TLR9-dependent innate immune activators and vaccine adjuvants. Four different types of immunostimulatory CpG ODNs (A/D, B/K, C, and P type) have been reported. A/D type ODNs are characterized by high IFN-α production but intrinsically form aggregates, hindering its good manufacturing practice grade preparation. In this study, we developed several D35-derived ODNs (a commonly used A/D type ODN), which were modified with the addition of a phosphorothioate polynucleotide tail (such as dAs40), and examined their physical properties, solubility in saline, immunostimulatory activity on human PBMCs, and vaccine adjuvant potential in monkeys. We found that two modified ODNs including D35-dAs40 and D35core-dAs40 were immunostimulatory, similar to original D35 in human PBMCs, resulting in high IFN-α secretion in a dose-dependent manner. Physical property analysis by dynamic light scattering revealed that both D35-dAs40 and D35core-dAs40 did not form aggregates in saline, which is currently impossible for the original D35. Furthermore, D35-dAs40 and D35core-dAs40 worked as better vaccine adjuvant in monkeys. These results suggested that D35-dAs40 and D35core-dAs40 are two promising prototypes of nonaggregating A/D type ODN with advantages of ease of drug preparation for clinical applications as vaccine adjuvants or IFN-α inducing immunomodifiers.
- Published
- 2015
- Full Text
- View/download PDF
24. Olfactory plays a key role in spatiotemporal pathogenesis of cerebral malaria.
- Author
-
Zhao H, Aoshi T, Kawai S, Mori Y, Konishi A, Ozkan M, Fujita Y, Haseda Y, Shimizu M, Kohyama M, Kobiyama K, Eto K, Nabekura J, Horii T, Ishino T, Yuda M, Hemmi H, Kaisho T, Akira S, Kinoshita M, Tohyama K, Yoshioka Y, Ishii KJ, and Coban C
- Subjects
- Animals, CD8-Positive T-Lymphocytes immunology, Chemokine CCL21 genetics, Chemokine CCL21 immunology, Female, Humans, Malaria, Cerebral genetics, Malaria, Cerebral immunology, Malaria, Cerebral pathology, Male, Mice, Mice, Inbred C57BL, Olfactory Bulb immunology, Olfactory Bulb pathology, Plasmodium falciparum pathogenicity, Receptors, CCR7 genetics, Receptors, CCR7 immunology, Receptors, CXCR3 genetics, Receptors, CXCR3 immunology, Virulence, Malaria, Cerebral parasitology, Olfactory Bulb parasitology, Plasmodium falciparum physiology
- Abstract
Cerebral malaria is a complication of Plasmodium falciparum infection characterized by sudden coma, death, or neurodisability. Studies using a mouse model of experimental cerebral malaria (ECM) have indicated that blood-brain barrier disruption and CD8 T cell recruitment contribute to disease, but the spatiotemporal mechanisms are poorly understood. We show by ultra-high-field MRI and multiphoton microscopy that the olfactory bulb is physically and functionally damaged (loss of smell) by Plasmodium parasites during ECM. The trabecular small capillaries comprising the olfactory bulb show parasite accumulation and cell occlusion followed by microbleeding, events associated with high fever and cytokine storm. Specifically, the olfactory upregulates chemokine CCL21, and loss or functional blockade of its receptors CCR7 and CXCR3 results in decreased CD8 T cell activation and recruitment, respectively, as well as prolonged survival. Thus, early detection of olfaction loss and blockade of pathological cell recruitment may offer potential therapeutic strategies for ECM., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
25. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
- Author
-
Fujimoto K, Karuppuchamy T, Takemura N, Shimohigoshi M, Machida T, Haseda Y, Aoshi T, Ishii KJ, Akira S, and Uematsu S
- Subjects
- Animals, Antigens, CD immunology, Antigens, CD metabolism, CD8 Antigens immunology, CD8 Antigens metabolism, CD8-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes metabolism, Cell Proliferation, Cells, Cultured, Cytotoxicity, Immunologic immunology, Dendritic Cells metabolism, Flow Cytometry, Forkhead Transcription Factors immunology, Forkhead Transcription Factors metabolism, Integrin alpha Chains immunology, Integrin alpha Chains metabolism, Interleukin-12 Subunit p40 immunology, Interleukin-12 Subunit p40 metabolism, Interleukin-6 immunology, Interleukin-6 metabolism, Intestinal Mucosa immunology, Intestinal Mucosa metabolism, Intestine, Small metabolism, Mice, Mice, Inbred C57BL, Mice, Transgenic, Reverse Transcriptase Polymerase Chain Reaction, T-Lymphocytes, Cytotoxic metabolism, T-Lymphocytes, Regulatory immunology, T-Lymphocytes, Regulatory metabolism, Th1 Cells metabolism, Toll-Like Receptor 3 genetics, Toll-Like Receptor 3 immunology, Toll-Like Receptor 3 metabolism, Toll-Like Receptor 7 genetics, Toll-Like Receptor 7 immunology, Toll-Like Receptor 7 metabolism, Toll-Like Receptor 9 genetics, Toll-Like Receptor 9 immunology, Toll-Like Receptor 9 metabolism, Toll-Like Receptors genetics, Toll-Like Receptors metabolism, Dendritic Cells immunology, Intestine, Small immunology, T-Lymphocytes, Cytotoxic immunology, Th1 Cells immunology, Toll-Like Receptors immunology
- Abstract
CD103(+) dendritic cells (DCs) are the major conventional DC population in the intestinal lamina propria (LP). Our previous report showed that a small number of cells in the LP could be classified into four subsets based on the difference in CD11c/CD11b expression patterns: CD11c(hi)CD11b(lo) DCs, CD11c(hi)CD11b(hi) DCs, CD11c(int)CD11b(int) macrophages, and CD11c(int)CD11b(hi) eosinophils. The CD11c(hi)CD11b(hi) DCs, which are CD103(+), specifically express TLR5 and induce the differentiation of naive B cells into IgA(+) plasma cells. These DCs also mediate the differentiation of Ag-specific Th17 and Th1 cells in response to flagellin. We found that small intestine CD103(+) DCs of the LP (LPDCs) could be divided into a small subset of CD8α(+) cells and a larger subset of CD8α(-) cells. Flow cytometry analysis revealed that CD103(+)CD8α(+) and CD103(+)CD8α(-) LPDCs were equivalent to CD11c(hi)CD11b(lo) and CD11c(hi)CD11b(hi) subsets, respectively. We analyzed a novel subset of CD8α(+) LPDCs to elucidate their immunological function. CD103(+)CD8α(+) LPDCs expressed TLR3, TLR7, and TLR9 and produced IL-6 and IL-12p40, but not TNF-α, IL-10, or IL-23, following TLR ligand stimulation. CD103(+)CD8α(+) LPDCs did not express the gene encoding retinoic acid-converting enzyme Raldh2 and were not involved in T cell-independent IgA synthesis or Foxp3(+) regulatory T cell induction. Furthermore, CD103(+)CD8α(+) LPDCs induced Ag-specific IgG in serum, a Th1 response, and CTL activity in vivo. Accordingly, CD103(+)CD8α(+) LPDCs exhibit a different function from CD103(+)CD8α(-) LPDCs in active immunity. This is the first analysis, to our knowledge, of CD8α(+) DCs in the LP of the small intestine.
- Published
- 2011
- Full Text
- View/download PDF
26. Critical role for chicken Rad17 and Rad9 in the cellular response to DNA damage and stalled DNA replication.
- Author
-
Kobayashi M, Hirano A, Kumano T, Xiang SL, Mihara K, Haseda Y, Matsui O, Shimizu H, and Yamamoto K
- Subjects
- Amino Acid Sequence, Animals, B-Lymphocytes drug effects, B-Lymphocytes metabolism, B-Lymphocytes radiation effects, Cell Cycle Proteins genetics, Chickens, DNA-Binding Proteins, Hydroxyurea pharmacology, Molecular Sequence Data, Nucleic Acid Synthesis Inhibitors pharmacology, S Phase physiology, Time Factors, Ultraviolet Rays, X-Rays, Cell Cycle Proteins metabolism, DNA Damage physiology, DNA Replication physiology
- Abstract
The Rad17-replication factor C (Rad17-RFC) and Rad9-Rad1-Hus1 complexes are thought to function in the early phase of cell-cycle checkpoint control as sensors for genome damage and genome replication errors. However, genetic analysis of the functions of these complexes in vertebrates is complicated by the lethality of these gene disruptions in embryonic mouse cells. We disrupted the Rad17 and Rad9 loci by gene targeting in the chicken B lymphocyte line DT40. Rad17-/- and Rad9-/- DT40 cells are viable, and are highly sensitive to UV irradiation, alkylating agents, and DNA replication inhibitors, such as hydroxyurea. We further found that Rad17-/- and Rad9-/- but not ATM-/- cells are defective in S-phase DNA damage checkpoint controls and in the cellular response to stalled DNA replication. These results indicate a critical role for chicken Rad17 and Rad9 in the cellular response to stalled DNA replication and DNA damage.
- Published
- 2004
- Full Text
- View/download PDF
27. Concentration and clearance of Tc-99m-pyridoxylidene isoleucine by a hepatoma.
- Author
-
Ueno K and Haseda Y
- Subjects
- Aged, Colloids, Humans, Male, Radionuclide Imaging, Carcinoma, Hepatocellular diagnostic imaging, Isoleucine analogs & derivatives, Liver Neoplasms diagnostic imaging, Organotechnetium Compounds, Pyridoxal analogs & derivatives, Technetium
- Abstract
Usually hepatic tumors show focal defects on both Tc-99m-colloid liver and Tc-99m-hepatobiliary imaging. This report involves a rare case in which a hepatoma did not take up Tc-99m-phytate, but concentrated and cleared a Tc-99m-hepatobiliary agent, Tc-99m-pyridoxylidene isoleucine.
- Published
- 1980
- Full Text
- View/download PDF
28. [Transient hypothalamic hypothyroidism associated with hyperglycemic hyperosmolar nonketoacidotic coma (HHNK) precipitated by acute myocardial infarction in an aged diabetic (author's transl)].
- Author
-
Miwa U, Mori K, Sakato S, Haseda Y, Yoshino K, Sato T, Yamamoto H, Onoe T, Kawamura Y, Oka T, and Kinoshita Y
- Subjects
- Aged, Female, Humans, Brain Diseases etiology, Diabetes Complications, Diabetic Coma etiology, Hyperglycemic Hyperosmolar Nonketotic Coma etiology, Hypothalamo-Hypophyseal System physiopathology, Hypothyroidism etiology, Myocardial Infarction complications
- Published
- 1979
- Full Text
- View/download PDF
29. [A case of primary alveolar hypoventilation with diabetes mellitus (author's transl)].
- Author
-
Yamamoto H, Miwa U, Sakato S, Mori K, Haseda Y, Yoshino K, Sato T, Onoe T, Kawamura Y, Ooka T, and Kinoshita Y
- Subjects
- Female, Humans, Middle Aged, Diabetes Complications, Sleep Apnea Syndromes complications
- Published
- 1980
- Full Text
- View/download PDF
30. [A suggestive case of Crohn disease with macroamylasemia (author's transl)].
- Author
-
Haseda Y, Mori K, Sato T, Onoe T, Miwa U, Kawamura Y, Ooka T, Kinosita Y, Yamamoto M, and Takeda R
- Subjects
- Crohn Disease complications, Humans, Male, Middle Aged, Protein-Losing Enteropathies complications, Protein-Losing Enteropathies enzymology, Amylases blood, Crohn Disease enzymology
- Published
- 1979
31. Radionuclide angiography in two cases of hepatic actinomycosis.
- Author
-
Ueno K, Kabuto H, Haseda Y, Yamada T, and Nakagawa M
- Subjects
- Aged, Diagnosis, Differential, Female, Gallium Radioisotopes, Humans, Liver diagnostic imaging, Liver Neoplasms diagnosis, Male, Middle Aged, Phytic Acid, Radionuclide Imaging, Technetium, Actinomycosis diagnostic imaging, Liver Circulation, Liver Diseases diagnostic imaging, Organotechnetium Compounds
- Abstract
Primary hepatic actinomycosis is rare, and there have been few reports concerning its nuclear imaging findings. Two cases of actinomycosis, in which hypervascular hepatic masses were observed in the arterial phase of radionuclide angiography are reported. To the authors' knowledge, this finding has not been reported in the literature. In one of the two cases, intense Ga-67 uptake also was noted. Although the preoperative diagnosis based on the findings of nuclear imaging (liver scan, liver flow study, Ga-67 scan), ultrasound, CT, and angiography was hepatoma, hepatic masses in our cases proved to be hepatic actinomycosis. Because hepatic actinomycosis is rare, this disease is neglected often in the differential diagnosis of hepatic mass lesions. It should be included in the gamut of hypervascular hepatic mass lesions.
- Published
- 1986
- Full Text
- View/download PDF
32. Intraosseous lipoma of the skull: a report of two cases.
- Author
-
Yasuda Y, Tsukada S, Okada T, and Haseda Y
- Subjects
- Adult, Child, Exostoses complications, Exostoses pathology, Exostoses surgery, Female, Humans, Lipoma complications, Lipoma pathology, Male, Skull Neoplasms complications, Skull Neoplasms pathology, Frontal Bone, Lipoma surgery, Parietal Bone, Skull Neoplasms surgery
- Abstract
Case histories of a 12-year-old boy and a 20-year-old woman with hyperostosis of the frontoparietal bones are presented. Microscopical examination of the lesions showed intraosseous lipoma with hyperostosis of diploë. In both cases, only the prominent part of the tumor was removed for cosmetic reasons. The results were satisfactory, and there was no evidence of recurrence over a period of six years.
- Published
- 1987
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.